Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 25, Number 10—October 2019
Synopsis

Global Epidemiology of Diphtheria, 2000–20171

Kristie E.N. ClarkeComments to Author , Adam MacNeil, Stephen Hadler, Colleen Scott, Tejpratap S.P. Tiwari, and Thomas Cherian2
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (K.E.N. Clarke, A. MacNeil, S. Hadler, C. Scott, T.S.P. Tiwari); World Health Organization, Geneva, Switzerland (T. Cherian)

Main Article

Figure 6

Percentage of diphtheria case-patients >15 years of age, by national DTP3 coverage, 2000–2017. Each circle represents a country, and its size is proportionate to the average number of cases reported from the country per year of data in the dataset. The largest data point represents a large number of cases in a single year among Rohingya refugees from Myanmar. The vaccination coverage of the Rohingya population is unknown; therefore, the average of DTP3 coverage of Rakhine State in Myanmar fro

Figure 6. Percentage of diphtheria case-patients >15 years of age, by national DTP3 coverage, 2000–2017. Each circle represents a country, and its size is proportionate to the average number of cases reported from the country per year of data in the dataset. The largest data point represents a large number of cases in a single year among Rohingya refugees from Myanmar. The vaccination coverage of the Rohingya population is unknown; therefore, the average of DTP3 coverage of Rakhine State in Myanmar from 2016–2017 was used (18). DTP3, diphtheria–tetanus–pertussis vaccine; UNICEF, United Nations Children’s Fund; WHO, World Health Organization.

Main Article

References
  1. Zakikhany  K, Efstratiou  A. Diphtheria in Europe: current problems and new challenges. Future Microbiol. 2012;7:595–607. DOIPubMedGoogle Scholar
  2. World Health Organization. World Health Organization expanded programme on immunization. WHA2757. Geneva. Organization. 1974;•••:28–9.
  3. Galazka  A. Implications of the diphtheria epidemic in the Former Soviet Union for immunization programs. J Infect Dis. 2000;181(Suppl 1):S244–8. DOIPubMedGoogle Scholar
  4. Galazka  A. The changing epidemiology of diphtheria in the vaccine era. J Infect Dis. 2000;181(Suppl 1):S2–9. DOIPubMedGoogle Scholar
  5. Golaz  A, Hardy  IR, Strebel  P, Bisgard  KM, Vitek  C, Popovic  T, et al. Epidemic diphtheria in the Newly Independent States of the Former Soviet Union: implications for diphtheria control in the United States. J Infect Dis. 2000;181(Suppl 1):S237–43. DOIPubMedGoogle Scholar
  6. Dravid  MN, Joshi  SA. Resurgence of diphtheria in Malegaon & Dhule regions of north Maharashtra. Indian J Med Res. 2008;127:616–7.PubMedGoogle Scholar
  7. Landazabal García  N, Burgos Rodríguez  MM, Pastor  D. Diphtheria outbreak in Cali, Colombia, August-October 2000. Epidemiol Bull. 2001;22:13–5.PubMedGoogle Scholar
  8. Dandinarasaiah  M, Vikram  BK, Krishnamurthy  N, Chetan  AC, Jain  A. Diphtheria re-emergence: problems faced by developing countries. Indian J Otolaryngol Head Neck Surg. 2013;65:314–8. DOIPubMedGoogle Scholar
  9. World Health Organization. JRF supplementary questionnaire on surveillance. Geneva: The Organization; 2018 [cited 2018 Oct 20]. https://www.who.int/immunization/monitoring_surveillance/burden/vpd/JRF_Supplementary_Questionnaire_Surveillance_18Mar.pdf
  10. World Health Organization. Reported immunization schedules by vaccine. Geneva: The Organization; 2018 [cited 2018 Oct 20]. http://www.who.int/immunization/monitoring_surveillance/data
  11. European Centre for Disease Prevention and Control. Vaccine Scheduler: vaccine schedules in all countries of the European Union. Stockholm: The Centre; 2018 [cited 2018 Oct 20]. https://vaccine-schedule.ecdc.europa.eu
  12. World Health Organization. Immunization provided at school. Geneva: The Organization; 2017 [cited 2018 Oct 20]. http://www.who.int/immunization/monitoring_surveillance/data
  13. World Health Organization. Reported estimates of DTP4 coverage. Geneva: The Organization; 2018 [cited 2018 Aug 29]. http://apps.who.int/immunization_monitoring/globalsummary/timeseries/tscoveragedtp4.html
  14. World Health Organization. Diphtheria vaccine: WHO position paper—August 2017. Geneva: The Organization; 2017 [cited 2019 Jul 16]. https://www.who.int/immunization/policy/position_papers/diphtheria
  15. World Health Organization. Tetanus vaccines: WHO position pape—February 2017. Geneva: The Organization, 2017 [cited 2019 Jul 16]. https://www.who.int/immunization/policy/position_papers/tetanus
  16. World Health Organization. WHO–UNICEF estimates of DTP3 coverage 1980–2017. Geneva: The Organization; 2018 [cited 2018 Oct 20]. http://apps.who.int/immunization_monitoring/globalsummary/timeseries/tswucoveragedtp3.html
  17. MacNeil  A, Dietz  V, Cherian  T. Vaccine preventable diseases: time to re-examine global surveillance data? Vaccine. 2014;32:2315–20. DOIPubMedGoogle Scholar
  18. Bahl  S, editor. Diphtheria outbreak response—Cox’s Bazar, Bangladesh. World Health Organization Strategic Advisory Group of Experts. Geneva: The Organization; 2018 [cited 2019 Jul 16]. http://www.searo.who.int/bangladesh/reportdiph
  19. Hadler  SC, Acosta  A, Tiwari  T, Patel  M, editors. Diphtheria: a re-emerging threat in countries affected by conflict, migration, and social disruption. Atlanta: Emory University; 2019.
  20. European Centre for Disease Prevention and Control. Gap analysis on securing diphtheria diagnostic capacity and diphtheria antitoxin availability in the EU/EEA. Stockholm: The Centre; July 2017 [cited 2019 May 21]. https://ecdc.europa.eu/en/publications-data/gap-analysis-securing-diphtheria-diagnostic-capacity-and-diphtheria-antitoxin
  21. World Health organization. WHO–recommended standards for surveillance of selected vaccine-preventable diseases. Geneva: The Organization; 2014. p. 10–2 [cited 2018 Oct 20]. https://www.who.int/immunization/monitoring_surveillance/burden/vpd/WHO_SurveillanceVaccinePreventable_04_Diphtheria_R2.pdf
  22. Larson  HJ, de Figueiredo  A, Xiahong  Z, Schulz  WS, Verger  P, Johnston  IG, et al. The state of vaccine confidence 2016: global insights through a 67-country survey. EBioMedicine. 2016;12:295–301. DOIPubMedGoogle Scholar
  23. VanderEnde  K, Gacic-Dobo  M, Diallo  MS, Conklin  LM, Wallace  AS. Global routine vaccination coverage—2017. MMWR Morb Mortal Wkly Rep. 2018;67:1261–4. DOIPubMedGoogle Scholar
  24. Gavi. Gavi board starts framing alliance’s approach to 2021–2025 period. Geneva: Gavi; 2018 [cited 2018 Nov 29]. https://www.gavi.org/library/news/press-releases/2018/gavi-board-starts-framing-alliance-s-approach-to-2021-2025-period
  25. Durrheim  DN, Crowcroft  NS, Strebel  PM. Measles - The epidemiology of elimination. Vaccine. 2014;32:6880–3. DOIPubMedGoogle Scholar

Main Article

1Preliminary results from this study were presented at the meeting of the Strategic Advisory Group of Experts on Immunization, Geneva, Switzerland, April 25–27, 2017.

2Retired.

Page created: September 17, 2019
Page updated: September 17, 2019
Page reviewed: September 17, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external